SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002499
Filing Date
2019-04-23
Accepted
2019-04-23 16:05:01
Documents
5
Period of Report
2019-06-07
Effectiveness Date
2019-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238522zdef14a.htm DEF 14A 348033
2 G566827.JPG g566827.jpg GRAPHIC 13375
3 G769182.JPG g769182.jpg GRAPHIC 10164
4 G27062BGI001.GIF g27062bgi001.gif GRAPHIC 111204
5 G27062BGI002.GIF g27062bgi002.gif GRAPHIC 74044
  Complete submission text file 0001047469-19-002499.txt   637139
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 19761610
SIC: 2834 Pharmaceutical Preparations